2007
DOI: 10.1016/j.vaccine.2007.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
33
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 30 publications
(35 citation statements)
references
References 37 publications
1
33
0
Order By: Relevance
“…The efficacy of a CTL-based influenza vaccine was first evaluated in a C57BL/6 mouse model with an H-2 b -restricted CTL epitope, NP 366-374 , which was derived from nucleoprotein (NP) of H3N2 influenza virus (33). The liposome-coupled peptide NP 366-374 induced antigen-specific CTLs and successfully suppressed replication of H3N2 influenza virus in the lungs of the C57BL/6 mice.…”
Section: Development Of a Ctl-based Universal Influenza Vaccinementioning
confidence: 99%
“…The efficacy of a CTL-based influenza vaccine was first evaluated in a C57BL/6 mouse model with an H-2 b -restricted CTL epitope, NP 366-374 , which was derived from nucleoprotein (NP) of H3N2 influenza virus (33). The liposome-coupled peptide NP 366-374 induced antigen-specific CTLs and successfully suppressed replication of H3N2 influenza virus in the lungs of the C57BL/6 mice.…”
Section: Development Of a Ctl-based Universal Influenza Vaccinementioning
confidence: 99%
“…Ag chemically coupled to the surfaces of liposomes composed of unsaturated fatty acids has been shown to be presented to CD8 ϩ T cells (42) and to induce protective immunity against influenza virus (27). For further evaluation of the use of surface-linked liposomal peptide as an antiviral vaccine, we chose an immunodominant CTL epitope, GP33-41, of LCMV, which is presented by the H-2D b molecule (10,16,36).…”
Section: Induction Of Lcmv-specific Cd8mentioning
confidence: 99%
“…Furthermore, the cross-presentation of OVA coupled to liposomes consisting of unsaturated fatty acids was further confirmed by the in vivo induction of cytotoxic T lymphocytes (CTLs) which conferred tumor eradication (42) and protection against influenza virus (27) in mice. However, the advantages of the surface-linked liposomal peptides for other forms of vaccines, especially regarding the efficiency of effector CD8 ϩ T cells and the inducibility of long-term memory CD8 ϩ T cells, have not been demonstrated.…”
mentioning
confidence: 95%
“…Surface-linked liposomal peptide has been shown to serves as an effective vaccine without showing detrimental effects in the presence of immune potentiators [23,24]. Furthermore, influenza virosomes enhanced CTL (cytotoxic T lymphocyte) induction [25][26][27].…”
Section: ) Artificial Membrane Vaccine or Liposome Vaccinementioning
confidence: 99%